Implantable Drug Delivery Devices Sector: Growth Drivers and Challenges
Growth Drivers
- Emergence of Novel Medical Devices and Products
- Increasing Incidence of Chronic Diseases
Challenges
- High Cost of Implantable Drug Delivery Devices
- Stringent Government Regulations
Implantable Drug Delivery Devices Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
8.3% |
|
Base Year Market Size (2024) |
USD 29.4 billion |
|
Forecast Year Market Size (2037) |
USD 82.89 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of implantable drug delivery devices is assessed at USD 31.47 billion.
Implantable Drug Delivery Devices Market size was valued at USD 29.4 billion in 2024 and is expected to reach USD 82.89 billion by 2037, registering around 8.3% CAGR during the forecast period i.e., between 2025-2037.
Asia Pacific industry is predicted to account for largest revenue share by 2037, on account of steadily increasing healthcare expenditure and rising concern & awareness for the development of advanced devices in the region.
The major players in the market include Boston Scientific Corporation, Merck & Co., Inc., Medtronic Plc, Allergan, Inc., Abbott Laboratories, DSM Biomedical, Varian Medical Systems, Inc., and others.
